论坛:数字化心理健康

数字化心理健康服务中的伦理问题

  • 唐瑀蓁 ,
  • 张蕾 ,
  • 黄晶晶 ,
  • 杜江
展开
  • 上海交通大学医学院附属精神卫生中心, 上海 200030
唐瑀蓁,2021年6月毕业于北京师范大学心理学部,获理学学士学位,2021年9月起就读于上海交通大学医学院附属精神卫生中心,攻读应用心理专业硕士学位,研究方向为物质与行为成瘾领域。
*杜江 dujiangdou@163.com

网络出版日期: 2024-06-13

Ethical Issues in Digital Mental Health Services

  • TANG Yuzhen ,
  • ZHANG Lei ,
  • HUANG Jingjing ,
  • DU Jiang
Expand
  • Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China
*DU Jiang, dujiangdou@163.com

Online published: 2024-06-13

摘要

随着互联网飞速发展,数字技术在心理健康领域的应用逐渐增加。作为一种特殊的新兴医疗服务方式,数字化心理健康(digital mental health)的发展需要遵守伦理规范要求。文章从目前心理健康领域数字医疗的应用情况出发,对隐私与数据安全、透明性、公平性、知情同意与问责,以及人工智能(artificial intelligence,AI)心理咨询相关伦理问题进行讨论,以期引起关注,确保在该领域合理、合规地应用数字医疗技术。

本文引用格式

唐瑀蓁 , 张蕾 , 黄晶晶 , 杜江 . 数字化心理健康服务中的伦理问题[J]. 心理学通讯, 2022 , 5(1) : 9 -13 . DOI: 10.12100/j.issn.2096-5494.222003

Abstract

With the rapid development of the Internet, the use of digital technology in the field of mental health is gradually increasing. As a special emerging medical service modality, the development of digital mental health needs to comply with the requirements of ethical norms. Starting from the current application of digital health in the field of mental health, the article discusses the ethical issues related to privacy and data security, transparency, fairness, informed consent and accountability, and artificial intelligence (AI) psychological counseling in the hope of drawing attention to ensure a rational and compliant use of digital health technology in this field.

参考文献

[1] 动脉网·蛋壳研究院. (2021). 《中国数字疗法行业白皮书》(2021版). 2022-02-23 取自 https://max.book118.com/html/2021/0507/8051021062003100.shtm
[2] 段文萱, 石旭雯. (2019). 人工智能的伦理困境探讨. 中国医学伦理学,32(8), 977-980. doi: 10.12026/j.issn.1001-8565.2019.08.05
[3] 国家市场监督管理总局, 国家标准化管理委员会. (2020). 《信息安全技术个人信息安全规范》. 2022-03-14 取自 https://www.secrss.com/articles/17713
[4] 国家药品监督管理局. (2022). 境内医疗器械(注册)数字医疗. 2022-03-26 取自https://www.nmpa.gov.cn/datasearch/search-result.html
[5] 国家药品监督管理局医疗器械技术审评中心. (2022). 医疗器械软件注册审查指导原则(2022年修订版). 2022-03-26 取自 https://www.cmde.org.cn/flfg/zdyz/zdyzwbk/20220309091706965.html
[6] 韩瑾. (2019). 网络与数字技术在心理健康领域的应用与发展展望. 心理学通讯, 2(2), 95-100
[7] 江光荣, 李丹阳, 任志洪, 闫玉朋, 伍新春, 朱旭, .. 张琳. (2021). 中国国民心理健康素养的现状与特点. 心理学报,53(2), 182-201. doi: 10.3724/SP.J.1041.2021.00182
[8] 刘荣. (2018). 智能医学中的安全问题. 中华腔镜外科杂志(电子版),11(1), 4-7. doi: 10.3877/cma.j.issn.1674-6899.2018.01.002
[9] 全国人民代表大会. (2021). 关于《中华人民共和国个人信息保护法(草案)》的说明. 2022-03-14 取自 http://www.npc.gov.cn/npc/c30834/202108/fbc9ba044c2449c9bc6b6317b94694be.shtml
[10] 栗克清. (2018). 中国精神卫生服务发展现状述评. 神经疾病与精神卫生(5), 3. doi: 10.3969/j.issn.1009-6574.2018.05.001
[11] 谢晋, 柳云, 郑瑞军, 那佳, 边林. (2021). 我国互联网医疗平台的伦理问题分析及对策建议. 中国医学伦理学, 34(4), 463-467+472. doi: 10.12026/j.issn.1001-8565.2021.04.10
[12] 中国互联网络信息中心. (2021). 第47次《中国互联网络发展状况统计报告》. 2022-02-23 取自 http://www.cac.gov.cn/2021-02/03/c_1613923423079314.htm
[13] Aboujaoude, E., & Gega, L. N. (2020). From digital mental health interventions to digital “addiction”: Where the two fields converge. Front Psychiatry, 10, 1017. doi: 10.3389/fpsyt.2019.01017
[14] Canady, V. A. (2020). FDA approves first video game Rx treatment for children with ADHD.Mental Health Weekly, 30(26), 1-7. doi: 10.1002/mhw.32423
[15] DeCamp, M., & Lindvall, C. (2020). Latent bias and the implementation of artificial intelligence in medicine. J Am Med Inform Assoc, 27(12), 2020-2023. doi: 10.1093/jamia/ocaa094
[16] Federal Trade Commission. (2016). Lumosity to pay $2 million to settle FTC deceptive advertising charges for its “brain training” program. 2022-02-23 取自 https://www.ftc.gov/news-events/news/press-releases/2016/01/lumosity-pay-2-million-settle-ftc-deceptive-advertising-charges-its-brain-training-program
[17] Food and Drug Administration. (2017). Digital health innovation action plan. Digital Health Program. 2022-02-23 取自 https://www.fda.gov/media/106331
[18] Fulmer R., Davis T., Costello C., & Joerin A. (2021). The ethics of psychological artificial intelligence: Clinical considerations.Counseling and Values, 66(2), 131-144. doi: 10.1002/cvj.12153
[19] Huang Y. Q., Wang Y., Wang H., Liu Z. R., Yu X., Yan J., .. Wu Y. (2019). Prevalence of mental disorders in China: A cross-sectional epidemiological study.Lancet Psychiatry, 6(3), 211-224. doi: 10.1016/S2215-0366(18)30511-X
[20] Kollins S. H., DeLoss D. J., Cañadas E., Lutz J., Findling R. L., Keefe R. S., .. Faraone S. V. (2020). A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): A randomised controlled trial. Lancet Digit Health, 2(4), e168-e178. doi: 10.1016/S2589-7500(20)30017-0
[21] Magrabi F., Ammenwerth E., Mcnair J. B., de Keizer N. F., Hyppönen H., Nykänen P., .. Georgiou A. (2019). Artificial intelligence in clinical decision support: challenges for evaluating AI and practical implications.Yearb Med Inform, 28(1), 128-134. doi: 10.1055/s-0039-1677903
[22] Marsch L. A., Campbell A., Campbell C., Chen C. H., Ertin E., Ghitza U., .. Young S. (2020). The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat, 112S, 4-11. doi: 10.1016/j.jsat.2020.02.005
[23] Martinez-Martin N., Greely H. T., & Cho M. K. (2021). Ethical development of digital phenotyping tools for mental health applications: Delphi study. JMIR MHealth UHealth, 9(7), e27343. doi: 10.2196/27343
[24] Mittelstadt, B. D., & Floridi, L. (2016). The ethics of big data: Current and foreseeable issues in biomedical contexts.Sci Eng Ethics, 22(2), 303-341. doi: 10.1007/s11948-015-9652-2
[25] Mittelstadt, B. (2019). Principles alone cannot guarantee ethical AI. NatureMachine Intelligence, 1(11), 501-507. doi: 10.1038/s42256-019-0114-4
[26] National Institute for Health and Care Excellence. (2019). Evidence standards framework for digital health technologies.Brit J Hosp Med, 80(4), 189.
[27] Obermeyer Z., Powers B., Vogeli C., & Mullainathan S. (2019). Dissecting racial bias in an algorithm used to manage the health of populations.Science, 366(6464), 447-453. doi: 10.1126/science.aax2342
[28] Pedersen, D. M. (1979). Dimensions of privacy.Percept Motor Skill, 48(3_suppl), 1291-1297. doi: 10.2466/pms.1979.48.3c.1291
[29] Pedersen, D. M. (1997). Psychological functions of privacy. J Environ Psychol, 17(2), 147-156. doi: 10.1006/jevp.1997.0049
[30] Potier, R. (2020). The digital phenotyping project: A psychoanalytical and network theory perspective. Front Psychol, 11, 1218. doi: 10.3389/fpsyg.2020.01218
[31] United States. (1996). Health insurance portability and accountability act of 1996. public law 104-191.US Statut Large, 110, 1936-2103.
[32] Warren E., Murray P., & Smith T. (2018). Letter to FDA on Regulation of Software as Medical Device. US Senator Elizabeth Warren of Massachusetts.
文章导航

/

〈 〉